Skip to main content
. 2020 Aug 20;123(9):1445–1455. doi: 10.1038/s41416-020-01032-y

Fig. 1. E2F7 expression is increased and correlated with poor outcomes.

Fig. 1

a, b Studies from the Oncomine datasets presented the increase in E2F7 mRNA in glioblastoma samples. c The expression of E2F7 in normal, astrocytoma, oligodendroglioma and glioblastoma tissues was detected by IHC. d The mRNA expression of E2F7 in normal, astrocytoma, oligodendroglioma and glioblastoma tissues was determined by qRT−PCR. e The clinical significance of E2F7 expression in glioma overall survivals was evaluated by Kaplan−Meier survival analyses. f The clinical significance of E2F7 expression in glioblastoma overall survivals was evaluated by Kaplan−Meier survival analyses.